MYELOCIDE

Welcome to the Brand page for “MYELOCIDE”, which is offered here for Antibody-targeted therapeutic agent for treatment of multiple myeloma;.

Its status is currently believed to be active. Its class is unavailable. “MYELOCIDE” is believed to be currently owned by “IMMUNOMEDICS, INC.”